Cargando…
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases
BACKGROUND: To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province. METHODS: Thirty-four indicators were selected b...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830847/ https://www.ncbi.nlm.nih.gov/pubmed/33494836 http://dx.doi.org/10.1186/s13690-021-00528-0 |
_version_ | 1783641506207236096 |
---|---|
author | Andreano, Anita Valsecchi, Maria Grazia Russo, Antonio Giampiero Siena, Salvatore |
author_facet | Andreano, Anita Valsecchi, Maria Grazia Russo, Antonio Giampiero Siena, Salvatore |
author_sort | Andreano, Anita |
collection | PubMed |
description | BACKGROUND: To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province. METHODS: Thirty-four indicators were selected by revision of main guidelines by cancer epidemiologists, and then evaluated by a multidisciplinary panel of clinicians involved in lung cancer care and working on the pathway of lung cancer diagnosis and treatment in the Lombardy region, Italy. With a modified Delphi method, they assessed for each indicator the content validity as a quality measure of the care pathway, the degree of modifiability from the health professional, and the relevance to the health professional. Feasibility was assessed using the cancer registry and the routine health records of the Lombardy region. Feasible indicators were then calculated in the cohort of lung cancer patients diagnosed in 2007–2012 derived from the cancer registry of the Milan Province. Criterion validity was assessed reviewing clinical records of a random sample of 114 patients (threshold for acceptable discordance ≤20%). Finally, reliability was evaluated at the provider level. RESULTS: Initially, 34 indicators were proposed for evaluation in the first Delphi round. Of the finally 22 selected indicators, 3 were not feasible because the required information was actually not available. The remaining 19 were calculated on the pilot cohort. After assessment of criterion validity (3 eliminated), 16 indicators were retained in the final set and evaluated for reliability. CONCLUSION: The developed and piloted set of indicators is now available to implement and monitor, over time, quality initiatives for lung cancer care in the studied health system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00528-0. |
format | Online Article Text |
id | pubmed-7830847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78308472021-01-26 Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases Andreano, Anita Valsecchi, Maria Grazia Russo, Antonio Giampiero Siena, Salvatore Arch Public Health Research BACKGROUND: To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province. METHODS: Thirty-four indicators were selected by revision of main guidelines by cancer epidemiologists, and then evaluated by a multidisciplinary panel of clinicians involved in lung cancer care and working on the pathway of lung cancer diagnosis and treatment in the Lombardy region, Italy. With a modified Delphi method, they assessed for each indicator the content validity as a quality measure of the care pathway, the degree of modifiability from the health professional, and the relevance to the health professional. Feasibility was assessed using the cancer registry and the routine health records of the Lombardy region. Feasible indicators were then calculated in the cohort of lung cancer patients diagnosed in 2007–2012 derived from the cancer registry of the Milan Province. Criterion validity was assessed reviewing clinical records of a random sample of 114 patients (threshold for acceptable discordance ≤20%). Finally, reliability was evaluated at the provider level. RESULTS: Initially, 34 indicators were proposed for evaluation in the first Delphi round. Of the finally 22 selected indicators, 3 were not feasible because the required information was actually not available. The remaining 19 were calculated on the pilot cohort. After assessment of criterion validity (3 eliminated), 16 indicators were retained in the final set and evaluated for reliability. CONCLUSION: The developed and piloted set of indicators is now available to implement and monitor, over time, quality initiatives for lung cancer care in the studied health system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00528-0. BioMed Central 2021-01-25 /pmc/articles/PMC7830847/ /pubmed/33494836 http://dx.doi.org/10.1186/s13690-021-00528-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Andreano, Anita Valsecchi, Maria Grazia Russo, Antonio Giampiero Siena, Salvatore Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases |
title | Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases |
title_full | Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases |
title_fullStr | Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases |
title_full_unstemmed | Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases |
title_short | Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases |
title_sort | indicators of guideline-concordant care in lung cancer defined with a modified delphi method and piloted in a cohort of over 5,800 cases |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830847/ https://www.ncbi.nlm.nih.gov/pubmed/33494836 http://dx.doi.org/10.1186/s13690-021-00528-0 |
work_keys_str_mv | AT andreanoanita indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases AT valsecchimariagrazia indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases AT russoantoniogiampiero indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases AT sienasalvatore indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases AT indicatorsofguidelineconcordantcareinlungcancerdefinedwithamodifieddelphimethodandpilotedinacohortofover5800cases |